Cephalic stimulation of gastrointestinal secretory and motor responses in humans

Gastroenterology. 1992 Aug;103(2):383-91. doi: 10.1016/0016-5085(92)90825-j.

Abstract

The present study was designed (a) to investigate the cephalic phase of gastropancreatic secretion, antroduodenal motility, and regulatory peptide release in six healthy young men and (b) to assess its regulation by the cholinergic system and endogenous cholecystokinin. Sham feeding performed for 15 minutes induced a concurrent stimulation of gastropancreatic secretion, antroduodenal motility, and pancreatic polypeptide release that lasted for 30 minutes. Reappearance of interdigestive phases III was retarded in the post-sham-fed state. Atropine abolished secretory, motor, and pancreatic polypeptide responses to sham feeding and enhanced gastrin release. The cholecystokinin receptor antagonist loxiglumide did not attenuate pancreatic enzyme response but diminished antral motor response by 72% (P less than 0.05) and release of pancreatic polypeptide by 91% (P less than 0.05); it enhanced gastrin release and abolished retardation of reappearance of phase III with sham feeding. It is concluded that (a) there is a distinct cephalic phase of gastropancreatic secretion, antroduodenal motility, and pancreatic polypeptide release in humans that is primarily under cholinergic control and that (b) endogenous cholecystokinin is involved in antral motor, gastrin, and pancreatic polypeptide responses to sham feeding.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Atropine / pharmacology
  • Brain / physiology*
  • Cholecystokinin / physiology
  • Eating / physiology*
  • Gastric Acid / metabolism*
  • Gastrins / blood
  • Gastrointestinal Motility*
  • Humans
  • Male
  • Pancreas / metabolism*
  • Pancreatic Polypeptide / blood
  • Proglumide / analogs & derivatives
  • Proglumide / pharmacology

Substances

  • Gastrins
  • Pancreatic Polypeptide
  • loxiglumide
  • Atropine
  • Cholecystokinin
  • Proglumide